Shearwater Capital — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
GPN Vaccines is a clinical-stage company developing vaccines against bacterial pathogens, including a vaccine to prevent pneumococcal disease.
BiotechHealthtechNew York, US
Timothy Hirst(Executive Officer, Director)James Selkirk(Executive Officer)in
Co-investorsForepont Capital PartnersKern Capital, LLC
Sitemate builds digital tools and workflow automation software for engineering, trades, and technical workforces across the built world, aiming to reduce administrative burden and increase productivity.
AI & Machine LearningConstruction TechFuture of WorkSaaS
Hartley(CEO)
Co-investorsArtesianBlackbird VenturesOIF VenturesOur Innovation FundSydney AngelsMarbruck
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.